Browse > Article
http://dx.doi.org/10.3746/jkfn.2017.46.6.759

Characterization of Anti-Advanced Glycation End Products (AGEs) and Radical Scavenging Constituents from Ainsliaea acerifolia  

Jeong, Gyeng Han (Department of Food Science and Biotechnology, Daegu University)
Kim, Tae Hoon (Department of Food Science and Biotechnology, Daegu University)
Publication Information
Journal of the Korean Society of Food Science and Nutrition / v.46, no.6, 2017 , pp. 759-764 More about this Journal
Abstract
Reactive oxygen species (ROS) and advanced glycation end products (AGEs) are valuable therapeutic targets for the regulation of diabetic complications. Activity-guided isolation of the ethylacetate (EtOAc)-soluble portion of 70% ethanolic extract from aerial parts of Ainsliaea acerifolia was performed, followed by AGE formation inhibition assay for the characterization of four dicaffeoylquinic acid derivatives of a previously known structure, methyl 3,5-di-O-caffeoyl-epi-quinate (1), 3,5-di-O-caffeoyl-epi-quinic acid (2), 4,5-di-O-caffeoyl-quinic acid (3), and methyl 4,5-di-O-caffeoyl-quinate (4). The structures of these compounds were confirmed by interpretation of nuclear magnetic resonance (NMR, $^1H-$, $^{13}C-NMR$, two-dimensional NMR) and mass spectroscopic data. Among the isolates, the major secondary metabolites, 3,5-di-O-caffeoyl-epi-quinic acid (2) and 4,5-di-O-caffeoyl-quinic acid (3) showed the most potent inhibitory effects against AGE formation with $IC_{50}$ values of $0.6{\pm}0.1{\mu}M$ and $0.4{\pm}0.1{\mu}M$, respectively. Furthermore, all isolated dicaffeoylquinic acid derivatives were evaluated for their radical scavenging activities using 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) radical, and compound 3 exhibited the most potent inhibitory effect in a concentration-dependent manner. This result suggests that the caffeoylquinic acid dimers isolated from A. acerifolia might be beneficial for the prevention of diabetic complications and related diseases.
Keywords
Ainsliaea acerifolia; diabetic complications; dicaffeoylquinic acid derivatives; advanced glycation end products (AGEs); $ABTS^+$;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Brownlee M. 2005. The pathobiology of diabetic complications: A unifying mechanism. Diabetes 54: 1615-1625.   DOI
2 Ahmed N. 2005. Advanced glycation endproducts-role in pathology of diabetic complications. Diabetes Res Clin Pract 67: 3-21.   DOI
3 Huebschmann AG, Regensteiner JG, Vlassara H, Reusch JE. 2006. Diabetes and advanced glycoxidation end products. Diabetes Care 29: 1420-1432.   DOI
4 Peyroux J, Sternberg M. 2006. Advanced glycation endproducts (AGEs): Pharmacological inhibition in diabetes. Pathol Biol 54: 405-419.   DOI
5 Matsuda H, Wang T, Managi H, Yoshikawa M. 2003. Structural requirements of flavonoids for inhibition of protein glycation and radical scavenging activities. Bioorg Med Chem 11: 5317-5323.   DOI
6 Edelstein D, Brownlee M. 1992. Mechanistic studies of advanced glycosylation end product inhibition by aminoguanidine. Diabetes 41: 26-29.
7 Ceriello A. 2003. New insights on oxidative stress and diabetic complications may lead to a "casual" antioxidant therapy. Diabetes Care 26: 1589-1596.   DOI
8 Stitt A, Gardiner TA, Anderson NL, Canning P, Frizzell N, Duffy N, Boyle C, Januszewski AS, Chachich M, Baynes JW, Thorpe SR. 2002. The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes. Diabetes 51: 2826-2832.   DOI
9 Doggrell SA. 2001. ALT-711 decreases cardiovascular stiffness and has potential in diabetes, hypertension and heart failure. Expert Opin Invest Drugs 10: 981-983.   DOI
10 Yokozawa T, Nakagawa T, Terasawa K. 2001. Effects of Oriental medicines on the production of advanced glycation endproducts. J Tradit Med 18: 107-112.
11 Islam MN, Ishita IJ, Jung HA, Choi JS. 2014. Vicenin 2 isolated from Artemisia capillaris exhibited potent anti-glycation properties. Food Chem Toxicol 69: 55-62.   DOI
12 Rahbar S, Figarola JL. 2003. Novel inhibitors of advanced glycation endproducts. Arch Biochem Biophys 419: 63-79.   DOI
13 Sugimoto S, Wanas AS, Mizuta T, Matsunami K, Kamel MS, Otsuka H. 2014. Structure elucidation of secondary metabolites isolated from the leaves of Ixora undulate and their inhibitory activity toward advanced glycation end-products formation. Phytochemistry 108: 189-195.   DOI
14 de Bernonville TD, Guyot S, Paulin JP, Gaucher M, Loufrani L, Henrion D, Derbre S, Guilet D, Richomme P, Dat JF, Brisset MN. 2010. Dihydrochalcones: Implication in resistance to oxidative stress and bioactivities against advanced glycation end-products and vasoconstriction. Phytochemistry 71: 443-452.   DOI
15 Choi SZ, Yang MC, Choi SU, Lee KR. 2006. Cytotoxic terpenes and lignans from the roots of Ainsliaea acerifolia. Arch Pharm Res 29: 203-208.   DOI
16 Kim HJ, Lee YS. 2005. Identification of new dicaffeoylquinic acids from Chrysanthemum morifolium and their antioxidant activities. Planta Med 71: 871-876.   DOI
17 Kim T, Jo C, Kim HS, Park YM, Wu YX, Cho JH, Kim TH. 2016. Chemical constituents from Ainsliaea acerifolia as potential anti-obesity agents. Phytochem Lett 16: 146-151.   DOI
18 Vinson JA, Howard III TB. 1996. Inhibition of protein glycation and advanced glycation end products by ascorbic acid and other vitamins and nutrients. J Nutr Biochem 7: 659-663.   DOI
19 Re R, Pellegrini N, Proteggente A, Pannala A, Yang M, Rice-Evans C. 1999. Antioxidant activity applying and improved ABTS radical cation decolorization assay. Free Radic Biol Med 26: 1231-1237.   DOI
20 Sato T, Iwaki M, Shimogaito N, Wu X, Yamagishi S, Takeuchi M. 2006. TAGE (toxic AGEs) theory in diabetic complications. Curr Mol Med 6: 351-358.   DOI
21 Tatefuji T, Izumi N, Ohta T, Arai S, Ikeda M, Kurimoto M. 1996. Isolation and identification of compounds from Brazilian propolis which enhance macrophage spreading and mobility. Biol Pharm Bull 19: 966-970.   DOI
22 Basnet P, Matsushige K, Hase K, Kadota S, Namba T. 1996. Four di-O-caffeoyl quinic acid derivatives from propolis. Potent hepatoprotective activity in experimental liver injury models. Biol Pharm Bull 19: 1479-1484.   DOI
23 Morel S, Helesbeux JJ, Séraphin D, Derbre S, Gatto J, Aumond MC, Abatuci Y, Grellier P, Beniddir MA, Pape PL, Pagniez F, Litaudon M, Landreau A, Richomme P. 2013. Anti-AGEs and antiparasitic activity of an original prenylated isoflavonoid and flavanones isolated from Derris ferruginea. Phytochem Lett 6: 498-503.   DOI
24 Ferchichi L, Derbre S, Mahmood K, Toure K, Guilet D, Litaudon M, Awang K, Hadi AHA, Le Ray AM, Richomme P. 2012. Bioguided fractionation and isolation of natural inhibitors of advanced glycation end-products (AGEs) from Calophyllum flavoramulum. Phytochemistry 78: 98-106.   DOI
25 Halliwell B. 1991. Drug antioxidant effects. Drugs 42: 569-605.   DOI
26 Rice-Evans CA, Miller NJ, Paganga G. 1996. Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic Biol Med 20: 933-956.   DOI
27 Lin KW, Wang BW, Wu CM, Yen MH, Wei BL, Hung CF, Lin CN. 2015. Antioxidant prenylated phenols of Artocarpus plants attenuate ultraviolet radiation-induced damage on human keratinocytes and fibroblasts. Phytochem Lett 14: 190-197.   DOI
28 Ponomarenko J, Trouillas P, Martin N, Dizhbite T, Krasilnikova J, Telysheva G. 2014. Elucidation of antioxidant properties of wood bark derived saturated diarylheptanoids: A comprehensive (DFT-supported) understanding. Phytochemistry 103: 178-187.   DOI